| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?
|
Tsiachristas, Apostolos
|
|
2016
|
2 |
3 |
p. 156-161
6 p.
|
artikel
|
| 2 |
First-in-human, double-blind, placebo-controlled, single-dose escalation study of aducanumab (BIIB037) in mild-to-moderate Alzheimer's disease
|
Ferrero, James
|
|
2016
|
2 |
3 |
p. 169-176
8 p.
|
artikel
|
| 3 |
Insufficient evidence for vitamin E in Alzheimer's disease
|
Hermann, Dirk M.
|
|
2016
|
2 |
3 |
p. 199-201
3 p.
|
artikel
|
| 4 |
NPT088 reduces both amyloid-β and tau pathologies in transgenic mice
|
Levenson, Jonathan M.
|
|
2016
|
2 |
3 |
p. 141-155
15 p.
|
artikel
|
| 5 |
Poor cerebrovascular function is an early marker of cognitive decline in healthy postmenopausal women
|
Wong, Rachel H.X.
|
|
2016
|
2 |
3 |
p. 162-168
7 p.
|
artikel
|
| 6 |
Profiling the dynamics of CSF and plasma Aβ reduction after treatment with JNJ-54861911, a potent oral BACE inhibitor
|
Timmers, Maarten
|
|
2016
|
2 |
3 |
p. 202-212
11 p.
|
artikel
|
| 7 |
Proof of concept demonstration of optimal composite MRI endpoints for clinical trials
|
Edland, Steven D.
|
|
2016
|
2 |
3 |
p. 177-181
5 p.
|
artikel
|
| 8 |
Quantile regression to characterize solanezumab effects in Alzheimer's disease trials
|
Chen, Yun-Fei
|
|
2016
|
2 |
3 |
p. 192-198
7 p.
|
artikel
|
| 9 |
Vitamin E family: Role in the pathogenesis and treatment of Alzheimer's disease
|
Boccardi, Virginia
|
|
2016
|
2 |
3 |
p. 182-191
10 p.
|
artikel
|
Tijdschrift beschrijving